{"explains":[],"count":15,"quotes":[{"exchange":"PNK","shortname":"ROCHE HOLDINGS AG SPN ADR EACH ","quoteType":"EQUITY","symbol":"RHHBY","index":"quotes","score":21351.0,"typeDisp":"Equity","longname":"Roche Holding AG","exchDisp":"OTC Markets","sector":"Healthcare","sectorDisp":"Healthcare","industry":"Drug Manufacturers—General","industryDisp":"Drug Manufacturers—General","dispSecIndFlag":true,"isYahooFinance":true},{"exchange":"PNK","shortname":"ROCHE HOLDINGS AG","quoteType":"EQUITY","symbol":"RHHVF","index":"quotes","score":20037.0,"typeDisp":"Equity","longname":"Roche Holding AG","exchDisp":"OTC Markets","sector":"Healthcare","sectorDisp":"Healthcare","industry":"Drug Manufacturers—General","industryDisp":"Drug Manufacturers—General","isYahooFinance":true},{"exchange":"PNK","shortname":"ROCHE HOLDINGS AG","quoteType":"EQUITY","symbol":"RHHBF","index":"quotes","score":20014.0,"typeDisp":"Equity","longname":"Roche Holding AG","exchDisp":"OTC Markets","sector":"Healthcare","sectorDisp":"Healthcare","industry":"Drug Manufacturers—General","industryDisp":"Drug Manufacturers—General","isYahooFinance":true},{"exchange":"MEX","shortname":"ROCHE HOLDINGS AG","quoteType":"EQUITY","symbol":"ROGN.MX","index":"quotes","score":20005.0,"typeDisp":"Equity","longname":"Roche Holding AG","exchDisp":"Mexico","sector":"Healthcare","sectorDisp":"Healthcare","industry":"Drug Manufacturers—General","industryDisp":"Drug Manufacturers—General","isYahooFinance":true}],"news":[{"uuid":"235d39be-0840-3dce-ae73-e6620251de87","title":"Roche to acquire Roivant's bowel disease drug for $7.1 billion","publisher":"Reuters","link":"https://finance.yahoo.com/news/roche-acquire-roivants-bowel-disease-051425831.html","providerPublishTime":1698038065,"type":"STORY","relatedTickers":["ROG.SW"]},{"uuid":"6834ce96-b04f-3a69-bedd-2090c36d1fb7","title":"Roche buys Telavant Holdings for $7.1 billion","publisher":"Reuters","link":"https://finance.yahoo.com/news/roche-buys-telavant-holdings-7-051042535.html","providerPublishTime":1698037842,"type":"STORY","relatedTickers":["ROG.SW"]},{"uuid":"c536a9f7-9044-3536-9029-1e674bcc1ba5","title":"[Ad hoc announcement pursuant to Art. 53 LR] Roche enters into a definitive agreement to acquire Telavant including rights to novel TL1A directed antibody (RVT-3101) for the treatment of inflammatory bowel disease from Roivant","publisher":"GlobeNewswire","link":"https://finance.yahoo.com/news/ad-hoc-announcement-pursuant-art-050000423.html","providerPublishTime":1698037200,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/z0H6pXm3u9bqaZm6Rh4lrw--~B/aD01Mjk7dz04MDE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/84b0110bbf60eb8397db0461bc3549c4","width":801,"height":529,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/YEYVwQ5wPaqEWQsgjuRKbA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/84b0110bbf60eb8397db0461bc3549c4","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["RHHBF","RHHBY","RHHVF"]},{"uuid":"a7070749-cb65-3400-8110-d7a9026bfaba","title":"Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease From Roivant","publisher":"GlobeNewswire","link":"https://finance.yahoo.com/news/roche-enters-definitive-agreement-acquire-050000139.html","providerPublishTime":1698037200,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/R35Zaer8vgFzoWKpttvTXg--~B/aD00MDA7dz0xNzI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/96e32f55c54dad2fb7c9058f4f7181f9","width":1724,"height":400,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/tF0lfw0d9KO_QJOCxlDbzA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/96e32f55c54dad2fb7c9058f4f7181f9","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["RHHBF","RHHBY","RHHVF","ROIV"]},{"uuid":"ddd532ae-a4b4-38e2-be97-fcd941f5e1cc","title":"Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?","publisher":"Motley Fool","link":"https://finance.yahoo.com/m/ddd532ae-a4b4-38e2-be97-fcd941f5e1cc/which-is-the-better-long-term.html","providerPublishTime":1697882400,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/SBqdsv.7_EStw9fwCckIZQ--~B/aD0xNDE0O3c9MjEyMTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/174f73f062a12cb0771404c91849a67e","width":2121,"height":1414,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/_ozWbSwz3Gh0.tF.x.spZg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/174f73f062a12cb0771404c91849a67e","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["PFE","ROG.SW"]},{"uuid":"43d4228a-a052-3e80-b9c4-4a5a80cc7ff0","title":"Health Care Roundup: Market Talk","publisher":"The Wall Street Journal","link":"https://finance.yahoo.com/m/43d4228a-a052-3e80-b9c4-4a5a80cc7ff0/health-care-roundup%3A-market.html","providerPublishTime":1697835720,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/.qtp8vrhfIy9YF8YYl2AIw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/415bd7691b51b7ebfe7e0ae603ef79b1","width":1280,"height":640,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/MHnKuXxa5d1pMTnI8ZV2jQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/415bd7691b51b7ebfe7e0ae603ef79b1","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["RHHBF","RHHBY","RHHVF","MKGAF","MKKGY"]},{"uuid":"84c5bed7-5731-33dc-a759-49e33fbf41d1","title":"Pharma Stock Roundup: JNJ Posts Upbeat Q3 Earnings, PFE, NVO Revise 2023 View","publisher":"Zacks","link":"https://finance.yahoo.com/news/pharma-stock-roundup-jnj-posts-130200563.html","providerPublishTime":1697806920,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/._mAv70PW7IAFz5cM1Tjpg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/65d4d9838ddb692fbe578219ce60c69d","width":635,"height":400,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/pvIyyMXLKwAjR2pqQ29s0Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/65d4d9838ddb692fbe578219ce60c69d","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["PFE","NVO","ROG.SW","4568.T"]},{"uuid":"d575bb5b-f689-3cf3-bd09-487d46d9dfc2","title":"Drug Giant Roche Skids As Covid Products Decline Weighs On Sales, Guidance","publisher":"Investor's Business Daily","link":"https://finance.yahoo.com/m/d575bb5b-f689-3cf3-bd09-487d46d9dfc2/drug-giant-roche-skids-as.html","providerPublishTime":1697745734,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/kIYSbIiQ_wBkBT6yiBwKIg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/3f7a1b49ffc83680f3b3ca72ce222ec8","width":1000,"height":563,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/oPVihfSMCU1kPfXgCbXYqQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/3f7a1b49ffc83680f3b3ca72ce222ec8","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["ROG.SW"]}],"nav":[{"navName":"Julia La Roche","navUrl":"https://www.yahoo.com/author/julia-la-roche"}],"lists":[{"slug":"the-fight-against-covid19","name":"The Fight Against COVID19","index":"the-fight-against-covid19","score":6.7981253,"type":"ALGO_WATCHLIST","brandSlug":"trea","pfId":"the_fight_against_covid19","symbolCount":13,"dailyPercentGain":-0.5484158039151487,"followerCount":23761,"iconUrl":"https://edgecast-img.yahoo.net/mysterio/api/3c7c7b592c7aba2beee72abb1e520b85d6241aee639ea2e8033b96962ad2e126/finance/resizefill_w96_h96/https://s.yimg.com/uc/fin/img/iStock-476433472.png","userId":"X3NJ2A7VDSABUI4URBWME2PZNM"},{"slug":"aging-baby-boomers","name":"Aging Baby Boomers","index":"aging-baby-boomers","score":1.1108263,"type":"ALGO_WATCHLIST","brandSlug":"yahoo-finance","pfId":"aging_baby_boomers","symbolCount":11,"dailyPercentGain":-1.1072322303050244,"followerCount":3768,"iconUrl":"https://edgecast-img.yahoo.net/mysterio/api/5012864ca85a18365b8dc6a2de4e4ce17202e825c0df84f19bf009dff0353aff/finance/resizefill_w96_h96/https://s.yimg.com/dh/ap/finance/portfolio/aging-baby-boomers.jpg","userId":"X3NJ2A7VDSABUI4URBWME2PZNM"}],"researchReports":[],"screenerFieldResults":[],"totalTime":83,"timeTakenForQuotes":439,"timeTakenForNews":600,"timeTakenForAlgowatchlist":400,"timeTakenForPredefinedScreener":400,"timeTakenForCrunchbase":0,"timeTakenForNav":400,"timeTakenForResearchReports":0,"timeTakenForScreenerField":0,"timeTakenForCulturalAssets":0}